id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-290001-603qy8ml	Pimentel, Lígia L.	Cholesterol, inflammation, and phospholipids: COVID-19 share traits with cardiovascular disease	2020-10-17		.txt	text/plain	1836	92	44	COVID-19, the severe acute respiratory syndrome produced by the coronavirus SARS-CoV-2, has resulted to date in more than 27 million infected cases and 900000 deaths worldwide since the first reported cases in December 2019 at the Chinese city of Wuhan (for updated information readers can consult https://covid19.who.int/). Moreover, total counts of white blood cells (WBC) were significantly higher in patients in critical condition [1] and those with severe respiratory failure showed macrophage activation syndrome [4], confirmed by the presence of monocyte recruiting chemokines in bronchoalveolar fluid [2] . Furthermore, plasma lipidomic analyses have revealed a close relationship between the severity of COVID-19 and circulating lipids: a combination of larger levels of atherogenic diglycerides (DG 16:0/20:2/20:0) and triglycerides (TG 14:0/22:1/22:3), alterations of the phosphatidylinositol (PI) signalling system with decreased concentrations of phosphatidylcholine (PC) [7] and sphingosine-1-phosphate (S1P) [8] . Thus, it was observed in SARS-CoV-2 positive subjects that anticardiolipin antibodies (aCL IgG) profile (>15 U/mL) was associated to disease severity (i.e.respiratory distress) while those patients have not a previous record history of thrombosis [11] .	./cache/cord-290001-603qy8ml.txt	./txt/cord-290001-603qy8ml.txt